The purpose of this study is to gather real world data on the performance of the EmboTrap Revascularization Device for the removal of blood clots in the setting of ischemic stroke. The EmboTrap® Revascularization Device is not experimental and is approved by regulatory agencies in the United States and in Europe for the removal of blood clots in the brain for acute ischemic stroke patients, however its use to reduce disability is still investigational in the US